论文部分内容阅读
Objective: To study the clinician recognition for clinical risk factors of of post-marketing Chinese Traditional Patent Medicine (CTPM).Methods: Structured interviews were carried out to Investigate 280 clinicians and analyse for 254 questionnaires.